News
177 - 180 of 326 news items
NHS England has today announced that NHS patients in England will be some of the first people in Europe to benefit from a new treatment for cystic fibrosis (CF). Three in five patients with the genetic condition could benefit from the ‘triple combination’ treatment produced by Vertex Pharmaceuticals, called ‘Kaftrio’, or ‘Trikafta’ in the US. The treatment tackles the underlying causes of CF by helping the lungs work effectively. Read more
Covid-19 patient Sam McQueen was transferred to Royal Brompton Hospital from Northwick Park Hospital on 22 March with severe Covid-19 related lung disease. In this moving video Sam shares his struggles battling Covid-19: from time on Royal Brompton Hospital’s Adult Intensive Care Unit, to gaining use of his hands and legs again, to the ‘infusion of energy’ he received at the thought of going home, and his gratitude to the NHS for saving his life. Watch video
All wards are still closed to visitors in response to coronavirus. We are continuing the current restrictions to visiting within our Trust until it is safe to re-instate limited visiting. Visitors will only be allowed in the exceptional circumstances. This has been a difficult decision to make but we feel we cannot prevent the risk of spreading the infection if we allow visitors back to our hospitals. Read more
Royal Brompton’s Adult Intensive Care Unit appeared on Channel 4 News last night (Monday, May 18th) as Health and Social Care Correspondent Victoria Macdonald reported on ECMO (extracorporeal membrane oxygenation machine) and how, when ventilation is no longer enough to keep a patient alive, ECMO is often the last hope for the sickest patents. Read more